Publicaciones en las que colabora con Vicente E. Climent-Payá (10)

2019

  1. Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

    Scientific Reports, Vol. 9, Núm. 1

2016

  1. Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy

    European Journal of Clinical Investigation, Vol. 46, Núm. 2, pp. 123-129

2015

  1. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy

    Journal of Internal Medicine, Vol. 278, Núm. 1, pp. 50-58

2014

  1. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy

    QJM, Vol. 107, Núm. 8, pp. 613-621

2013

  1. Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

    Annals of Medicine, Vol. 45, Núm. 4, pp. 341-347

2012

  1. Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

    European Journal of Internal Medicine, Vol. 23, Núm. 2, pp. 169-174

2010

  1. Enzyme replacement therapy in fabry disease: Influence on cardiac manifestations

    Current Medicinal Chemistry, Vol. 17, Núm. 16, pp. 1679-1689

  2. Plasma levels of Von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

    Thrombosis Research, Vol. 126, Núm. 1

  3. Serum Levels of high-sensitivity troponin T: A novel marker for cardiac remodeling in hypertrophic cardiomyopathy

    Journal of Cardiac Failure, Vol. 16, Núm. 12, pp. 950-956

2009

  1. Left atrial remodelling in hypertrophic cardiomyopathy: Relation with exercise capacity and biochemical markers of tissue strain and remodelling

    International Journal of Clinical Practice, Vol. 63, Núm. 10, pp. 1465-1471